CN105170205B - 一种基于微流控芯片技术构建的仿生芯片 - Google Patents
一种基于微流控芯片技术构建的仿生芯片 Download PDFInfo
- Publication number
- CN105170205B CN105170205B CN201510603772.9A CN201510603772A CN105170205B CN 105170205 B CN105170205 B CN 105170205B CN 201510603772 A CN201510603772 A CN 201510603772A CN 105170205 B CN105170205 B CN 105170205B
- Authority
- CN
- China
- Prior art keywords
- module
- chip
- perforated membrane
- absorption
- center hole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000005516 engineering process Methods 0.000 title claims abstract description 14
- 239000011664 nicotinic acid Substances 0.000 title abstract 7
- 239000003814 drug Substances 0.000 claims abstract description 31
- 238000010521 absorption reaction Methods 0.000 claims abstract description 27
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000012530 fluid Substances 0.000 claims abstract description 16
- 239000012930 cell culture fluid Substances 0.000 claims abstract description 10
- 230000010224 hepatic metabolism Effects 0.000 claims abstract description 10
- 230000002572 peristaltic effect Effects 0.000 claims abstract description 6
- 239000012528 membrane Substances 0.000 claims description 45
- 230000000857 drug effect Effects 0.000 claims description 24
- 210000004027 cell Anatomy 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 13
- 230000037361 pathway Effects 0.000 claims description 11
- 210000003556 vascular endothelial cell Anatomy 0.000 claims description 7
- 210000000577 adipose tissue Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 210000005229 liver cell Anatomy 0.000 claims description 6
- 210000004072 lung Anatomy 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 206010006187 Breast cancer Diseases 0.000 claims description 5
- 208000026310 Breast neoplasm Diseases 0.000 claims description 5
- 210000002216 heart Anatomy 0.000 claims description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- -1 Merlon Polymers 0.000 claims description 3
- 239000002359 drug metabolite Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000010453 quartz Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 230000008030 elimination Effects 0.000 abstract description 8
- 238000003379 elimination reaction Methods 0.000 abstract description 8
- 206010019851 Hepatotoxicity Diseases 0.000 abstract description 4
- 230000007686 hepatotoxicity Effects 0.000 abstract description 4
- 231100000304 hepatotoxicity Toxicity 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000001575 pathological effect Effects 0.000 abstract description 4
- 210000004379 membrane Anatomy 0.000 description 31
- 238000002474 experimental method Methods 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- 238000001514 detection method Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000000090 biomarker Substances 0.000 description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 3
- 210000001842 enterocyte Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229930012538 Paclitaxel Natural products 0.000 description 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 229960001592 paclitaxel Drugs 0.000 description 2
- 210000004738 parenchymal cell Anatomy 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229960003712 propranolol Drugs 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960001301 amobarbital Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000004651 carbonic acid esters Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510603772.9A CN105170205B (zh) | 2015-09-19 | 2015-09-19 | 一种基于微流控芯片技术构建的仿生芯片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510603772.9A CN105170205B (zh) | 2015-09-19 | 2015-09-19 | 一种基于微流控芯片技术构建的仿生芯片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105170205A CN105170205A (zh) | 2015-12-23 |
CN105170205B true CN105170205B (zh) | 2017-01-25 |
Family
ID=54892910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510603772.9A Active CN105170205B (zh) | 2015-09-19 | 2015-09-19 | 一种基于微流控芯片技术构建的仿生芯片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105170205B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110055176A (zh) * | 2019-04-29 | 2019-07-26 | 大连医科大学附属第二医院 | 仿生肺癌脑转移模型构建的微流控芯片及模型构建方法 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107955790B (zh) * | 2016-10-14 | 2021-10-15 | 中国科学院大连化学物理研究所 | 基于微流控芯片的模拟药物体内吸收过程的肠-肾体系 |
CN107955783B (zh) * | 2016-10-14 | 2021-11-30 | 中国科学院大连化学物理研究所 | 一种基于微流控芯片体外糖尿病肾小球模型的构建方法 |
CN107955775B (zh) * | 2016-10-14 | 2021-10-15 | 中国科学院大连化学物理研究所 | 一种仿生多能生物界面体系的微流控芯片及其制备方法 |
CN107955784B (zh) * | 2016-10-14 | 2021-10-15 | 中国科学院大连化学物理研究所 | 一种基于微流控芯片技术的三维细胞球迁移监测方法 |
CN106581761B (zh) * | 2016-12-07 | 2019-05-28 | 清华大学深圳研究生院 | 一种人工肝脏组织及其制作方法 |
CN106622411B (zh) * | 2016-12-19 | 2019-01-22 | 上海交通大学 | 一种微流控芯片及其制备方法和应用 |
PL234118B1 (pl) * | 2018-01-29 | 2020-01-31 | Politechnika Warszawska | Kardridż mikrodozownika do badania skuteczności terapii w warunkach przepływowych |
CN108504571B (zh) * | 2018-03-09 | 2021-12-31 | 清华大学深圳研究生院 | 一种人工肝小叶功能单元的构建装置及构建方法 |
CN109517737A (zh) * | 2018-11-06 | 2019-03-26 | 中国科学院过程工程研究所 | 一种微流控芯片和基于该芯片的肿瘤转移模型及模型构建方法和应用 |
CN109633115A (zh) * | 2019-01-08 | 2019-04-16 | 杭州霆科生物科技有限公司 | 一种水质综合毒性检测纸芯片 |
CN113545337B (zh) * | 2021-07-21 | 2022-08-26 | 益诺思生物技术南通有限公司 | 哺乳动物心脏瓣膜的定型方法 |
CN114081989B (zh) * | 2021-11-17 | 2023-02-28 | 迪格瑞医疗科技(苏州)有限公司 | 一种生物可降解栓塞微球及制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5786146B2 (ja) * | 2007-06-08 | 2015-09-30 | 安田 賢二 | モデル細胞チップ、モデル細胞チップによる薬効評価装置、および薬効評価方法 |
CN101199436A (zh) * | 2007-11-28 | 2008-06-18 | 中国人民解放军第三军医大学第一附属医院 | 三维立体式培养肝细胞的生物反应器 |
EP2730645A3 (en) * | 2008-06-04 | 2014-10-22 | TissUse GmbH | Organ-on-a-chip-device |
SG10201601434RA (en) * | 2011-02-28 | 2016-03-30 | Harvard College | Cell Culture System |
CN104826676B (zh) * | 2015-05-04 | 2016-08-24 | 清华大学深圳研究生院 | 微流控芯片、系统及其应用 |
-
2015
- 2015-09-19 CN CN201510603772.9A patent/CN105170205B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110055176A (zh) * | 2019-04-29 | 2019-07-26 | 大连医科大学附属第二医院 | 仿生肺癌脑转移模型构建的微流控芯片及模型构建方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105170205A (zh) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105170205B (zh) | 一种基于微流控芯片技术构建的仿生芯片 | |
Caplin et al. | Microfluidic organ‐on‐a‐chip technology for advancement of drug development and toxicology | |
Caballero et al. | Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient | |
Ramadan et al. | Organ-on-a-chip engineering: Toward bridging the gap between lab and industry | |
Thompson et al. | Mechanical stimulation: a crucial element of organ-on-chip models | |
Wang et al. | Microfluidic-based 3D engineered microvascular networks and their applications in vascularized microtumor models | |
Zhang et al. | Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors | |
Webster et al. | Development of microfluidic devices for biomedical and clinical application | |
US20140308688A1 (en) | Human emulated response with microfluidic enhanced systems | |
Wang et al. | Organ-on-a-chip platforms for drug delivery and cell characterization: A review | |
Regmi et al. | Applications of microfluidics and organ-on-a-chip in cancer research | |
Materne et al. | Chip-based liver equivalents for toxicity testing–organotypicalness versus cost-efficient high throughput | |
Liu et al. | Cell-based assays on microfluidics for drug screening | |
Li et al. | Microfluidic organ-on-a-chip system for disease modeling and drug development | |
Lee et al. | Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models | |
US10641761B2 (en) | Synthetic microfluidic systems for tumor metastasis | |
Dabbagh Moghaddam et al. | Application of microfluidic platforms in cancer therapy | |
CN108004144B (zh) | 一种含管道网络的器官芯片单元 | |
Li et al. | Advances in tumor-endothelial cells co-culture and interaction on microfluidics | |
Rothbauer et al. | A decade of organs-on-a-chip emulating human physiology at the microscale: a critical status report on progress in toxicology and pharmacology | |
Yan et al. | Organ-on-a-chip: A new tool for in vitro research | |
Ko et al. | Engineering organ-on-a-chip to accelerate translational research | |
Park et al. | Reconstruction of in vivo-like in vitro model: Enabling technologies of microfluidic systems for dynamic biochemical/mechanical stimuli | |
Ustun et al. | Glioma-on-a-chip models | |
Zhao et al. | Mechanical strain-enabled reconstitution of dynamic environment in organ-on-a-chip platforms: a review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170808 Address after: 215152 Jiangsu city of Suzhou province Xiangcheng District Huang Dai Zhen Min Road No. 6 Patentee after: ZHONGKE XINRAY (SUZHOU) BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 116024 Dalian high tech park, Liaoning Ling Road, No. 2 Patentee before: Dalian University of Technology |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231023 Address after: 519000 Office 835, No. 258 Haojiang Road, Hengqin, Zhuhai, Guangdong Province Patentee after: Zhongke Hesheng Biotechnology (Zhuhai Hengqin) Co.,Ltd. Address before: No. 6 Anmin Road, Huangdai Town, Xiangcheng District, Suzhou City Patentee before: ZHONGKE XINRAY (SUZHOU) BIOLOGICAL TECHNOLOGY Co.,Ltd. |